Liver cancer deaths are surging due to late diagnosis of the less survivable cancers

January 13, 2023

The British Liver Trust marked the Less Survivable Cancers Awareness Day by calling for urgent action from parliamentarians in Westminster, the Scottish Parliament and Welsh Senedd to tackle delays in diagnosis for deadly cancers leading to catastrophic outcomes. 

The British Liver Trust, along with the five other health charities form the Less Survivable Cancer Taskforce (LSCT) represent the six less survivable cancers, liver, lung, brain, oesophageal, pancreatic and stomach. Combined these cancers make up nearly half of all common cancer deaths in the UK.  

Shockingly, liver cancer is now the fastest rising cause of cancer death in the UK with almost 9 in 10 liver cancer patients dying within 5 years of being diagnosed (13% survival rate). Liver cancer is a silent killer as there are often no symptoms in its early stages. Symptoms include weight loss, jaundice, swelling in your abdomen and itchy skin.  

Over 40 MPs attended the LSCT event at Westminster on Wednesday and over 20 Members of the Scottish Parliament (MSPs) attended the Holyrood event on Tuesday including Public Health Minister Maree Todd MSP. 

Read more on our Liver Cancer UK website

More news

Our Budget Case to the Treasury: Investing in Prevention

Our Budget Case to the Treasury: Investing in Prevention

The Autumn Budget on 28th October is a chance to prevent thousands of families from experiencing the devastating impact of liver disease. Because 90% of liver disease is preventable, government action on alcohol harm and obesity could ...
Liver UK helps shape new European recommendations on liver cancer surveillance

Liver UK helps shape new European recommendations on liver cancer surveillance

A major new paper published in The Lancet Regional Health – Europe has highlighted the challenges of detecting liver cancer earlier across Europe and sets out practical lessons from countries around the world to improve surveillance ...
The LIVERAGE research studies

The LIVERAGE research studies

The LIVERAGE and LIVERAGE Cirrhosis studies are large clinical research studies for adults living with MASLD, a type of fatty liver disease. These studies focus on people with MASH, a more advanced form of MASLD.  The studies include ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.